¥­¥é¡¼¥×¥í¥Ð¥¤¥ª¥Æ¥£¥Ã¥¯G¡ÊSIBOÂкö¡Ë

¥­¥é¡¼¥×¥í¥Ð¥¤¥ª¥Æ¥£¥Ã¥¯G¡ÊSIBOÂкö¡Ë
  • ¥­¥é¡¼¥×¥í¥Ð¥¤¥ª¥Æ¥£¥Ã¥¯G¡ÊSIBOÂкö¡Ë [1]
  • ¥­¥é¡¼¥×¥í¥Ð¥¤¥ª¥Æ¥£¥Ã¥¯G¡ÊSIBOÂкö¡Ë [2]
·¿ÈÖOMPKPG
ÈÎÇä²Á³Ê

8,993±ß

¹ØÆþ¿ô

Killer Probiotic G/ Naturopathy
90 ¥«¥×¥»¥ë


¥­¥é¡¼¥×¥í¥Ð¥¤¥ª¥Æ¥£¥Ã¥¯G¤Ï¤³¤ó¤ÊÊý¤ËÁª¤Ð¤ì¤Æ¤¤¤Þ¤¹¡£

  • IJÆâºÙ¶ÝÁý¿£¾É¸õ·²¡ÊSIBO¡Ë¤Î¼£ÎÅ
  • ¥«¥ó¥¸¥¿¶Ý
  • °­¶Ì¶Ý¤Î½üµî
  • ¤ªÊ¢¤Ë¥¬¥¹¤ä¥ª¥Ê¥é¤¬Î¯¤Þ¤ê¤ä¤¹¤¤Êý
  • ²¼Î¡¤â¤·¤¯¤ÏÊØÈë¤Ë¤Ê¤ê¤ä¤¹¤¤Êý

IJÆâºÙ¶ÝÁý¿£¾É¸õ·²¡ÊSIBO¡Ë¤Î¸¶°ø

IJÆâºÙ¶Ý¡¢Ä²Æâ¥Õ¥í¡¼¥é¤Ê¤É¤¬¿Í´Ö¤Î·ò¹¯¤Ë¿§¡¹¤Ê±Æ¶Á¤òÍ¿¤¨¤Æ¤¤¤Þ¤¹¡£Ä²Æâ¤Ë¤ÏÈó¾ï¤Ë¿Íͤʶݤ¬Â¿¤¯À¸Â©¤·¤Æ¤¤¤Þ¤¹¤¬¡¢Ä²ÆâºÙ¶Ý¤¬ËÜÍèÀ¸Â©¿ô¤Î¾¯¤Ê¤¤¾®Ä²¤Ë¿¤¯ÈË¿£¤·¤¹¤®¤Æ¤·¤Þ¤Ã¤¿¾õÂÖ¤òIJÆâºÙ¶Ý°Û¾ïÁý¿£¾É¸õ·² SIBO¤È¸Æ¤Ó¤Þ¤¹¡£
¤³¤ÎSIBO¤ò°ú¤­µ¯¤³¤¹¸¶°ø¤Ï¡¢Â¿¼ï¿ÍͤǤ¹¤¬°Ê²¼¤Î¤³¤È¤¬¹Í¤¨¤é¤ì¤Þ¤¹¡£

  • ¿©ÃæÆÇ¡§ºÙ¶Ý´¶À÷¤Ë¤è¤êIJÆâ¥Õ¥í¡¼¥é¥Ð¥é¥ó¥¹¤¬Íð¤ì¤¿¤ê°ßIJ¤ÎêÀư±¿Æ°¤¬Íð¤ì¤ë¤³¤È¤¬¤¢¤ê¤Þ¤¹¡£
  • ¾Ã²½ÉÔÎÉ¡§Äã°ß»À¾É¡¢¾Ã²½¹ÚÁÇÉÔ­¡¢ÆýÅüÉÔÂÑÀ­¡¢¥°¥ë¥Æ¥óÉÔÂÑÀ­¤Ê¤É
  • ²¤ÊÆ·¿¤Î¹â»éËÿ©¡§Ä²Æâ¥Õ¥í¡¼¥é¤Ë°­À­¶Ý¤ÎȯÀ¸¤¬Áý¤¨¤ë¸¶°ø¤È¤Ê¤ê¤Þ¤¹¡£
  • êÀư±¿Æ°¤ÎÄã²¼¡§¾®Ä²Æâ¤Î¾Ã²½Ãæ¤Î¿©»ö¤äºÙ¶Ý¤ÏêÀư±¿Æ°¤Ë¤è¤êÂçIJ¤Ø¤È²¡¤·½Ð¤µ¤ì¤Þ¤¹¡£¤³¤ÎêÀư±¿Æ°¤¬¤·¤Ã¤«¤ê¤È¹Ô¤ï¤ì¤Ê¤¤¤ÈºÙ¶Ý¤Ï¾®Ä²Æâ¤ÇÈË¿£¤¹¤ëµ¡²ñ¤òÆÀ¤Æ¤·¤Þ¤¤¤Þ¤¹¡£
  • ²óÌÕÊۤε¡Ç½Äã²¼¡§ ²óÌÕÊۤϾ®Ä²¤ÈÂçIJ¤Ë´Ö¤Ë¤¢¤ê¡¢ÂçIJ¤«¤é¾®Ä²¤Ø¤ÎµÕή¤òͽËɤ·¤Æ¤¤¤Æ¤¯¤ì¤Þ¤¹¡£ÂçIJ¤Ë¤ÏÂçÎ̤κٶݤ¬À¸Â©¤·¤Æ¤¤¤Þ¤¹¤«¤é¡¢µÕή¤¬µ¯¤­¤ë¤ÈÂçÎ̤κٶݤ⾮IJ¤Ø¤È¿¯Æþ¤·¤Æ¤·¤Þ¤¤¤Þ¤¹¡£
    • IJÆâºÙ¶ÝÁý¿£¾É¸õ·²¡ÊSIBO¡Ë¤È´ØÏ¢¤Î¤¢¤ë°ßIJ¤Î¾É¾õ

      IJÆâºÙ¶Ý°Û¾ïÁý¿£¾É¸õ·²¡ÊSIBO¡Ë¤Î°ìÈ֤ξɾõ¤Ï¸ÝIJ¤äËÄËþ´¶¤Ç¤¹¡£Áý¤¨¤¹¤®¤¿Ä²ÆâºÙ¶Ý¤Ïú¿å²½Êª¤ä¿©ÊªÁ¡°Ý¤òȯ¹Ú¤·¤Æ¥¬¥¹¤òÂçÎ̤ËȯÀ¸¤µ¤»¤Þ¤¹¡£¤Þ¤¿¾Ã²½¤ò¼ÙË⤷¤¿¤ê¡¢Âå¼Õ¤ò˸¤²¤ë¤³¤È¤ÇÍÍ¡¹¤Ê¾É¾õ¤ò°ú¤­µ¯¤³¤·¤Þ¤¹¡£
      ¸ÝIJ¤äËÄËþ´¶°Ê³°¤Î¼ç¤Ê°ßIJ¤Î¾É¾õ¤È¤·¤Æ¤Ï

      • ²áÉÒÀ­Ä²¾É¸õ·²¡ÊIBS¡Ë
      • ¥ê¡¼¥­¡¼¥¬¥Ã¥È
      • ¥²¥Ã¥×¤äÅǤ­µ¤
      • Ê¢ÄË¡¢º¹¹þ¤ß
      • ²¼Î¡¤Þ¤¿¤ÏÊØÈë
      • ¶»¾Æ¤±

      SIBO(IJÆâºÙ¶ÝÁý¿£¾É¸õ·²)¤Î¼£ÎŤ˴ؤ·¤Æ¾Ü¤·¤¤¾ðÊó¤ÏDr.Ozawa¤Î¥Ö¥í¥°¤â¤´³Îǧ¤¯¤À¤µ¤¤¡£
      https://drsuppleusa.com/apps/note/?p=12339

      ¥«¥ó¥¸¥¿¶Ý¤Ë´Ø¤·¤Æ¾Ü¤·¤¤¾ðÊó¤ÏDr.Ozawa¤Î¥Ö¥í¥°¤â¤´³Îǧ¤¯¤À¤µ¤¤¡£
      https://ameblo.jp/dr-oz/entry-11932837757.html

      ¥­¥é¡¼¥×¥í¥Ð¥¤¥ª¥Æ¥£¥Ã¥¯G¤ÏÂΤÎÃæ¤Ç¤³¤ó¤ÊÉ÷¤ËƯ¤­¤Þ¤¹¡£

      ¤³¤ì¤Þ¤Ç¥×¥í¥Ð¥¤¥ª¥Æ¥£¥¯¥¹¤ÏSIBO¤ËÂФ·¤ÆµÕ¸ú²Ì¤È¤µ¤ì¤Æ¤­¤Þ¤·¤¿¤¬¡¢¤½¤ì¤ÏIJÆâºÙ¶Ý¤òÁý¤ä¤¹¤³¤È¤¬SIBO¤Î¾É¾õ¤ò°­²½¤µ¤»¤ë¤³¤È¤Ë·Ò¤¬¤ë¤¿¤á¤Ç¤¹¡£¥­¥é¡¼¥×¥í¥Ð¥¤¥ª¥Æ¥Ã¥¯G¤Î¡Ö¥Ð¥Á¥é¥¹¶Ý¤ÈÌȱ֥°¥í¥Ö¥ê¥óIgG¡×¤Ï¥À¥Ö¥ë¥¢¥¯¥·¥ç¥ó¤Ç¾®Ä²¤ÎIJÆâºÙ¶Ý¥Ð¥é¥ó¥¹¤òÀ°¤¨¤ë¡ÖÆÃÊ̤ʥץí¥Ð¥¤¥ª¥Æ¥£¥¯¥¹¡×¤Ç¤¹¡£

      ¥Ð¥Á¥é¥¹¶Ý¤Ï¾®Ä²¤ÇÁý¤¨²á¤®¤¿°­¶Ì¶Ý¤äÆüϸ«¶Ý¤òÂçÉý¤Ë¸º¤é¤·¤Æ¤¯¤ì¤Þ¤¹¡£¤½¤·¤ÆÌȱ֥°¥í¥Ö¥ê¥ó¤ÏºÙ¶Ý¤ÎÇËÊÒ¤äºÙ¶Ý¤«¤éÇӽФµ¤ì¤ëÆÇÁǤȷë¹ç¤·¤Æ¡¢¤½¤ì¤é¤ÎÆÇÁǤ¬µÛ¼ý¤µ¤ì¤ë¤Î¤ò¥Ö¥í¥Ã¥¯¡¢ÌµÆÇ²½¤·¤ÆÂγ°¤Ø¤ÎÇӽФµ¤»¤ë¤Î¤Ç¡¢Áý¤¨¤¹¤®¤¿¾®Ä²¤Î°­¶Ì¶Ý¤¬¸¶°ø¤Ç°ú¤­µ¯¤³¤µ¤ì¤ëÂÎÄ´ÉÔÎɤò²þÁ±¤·¤Þ¤¹¡£

      ÆâÍÆÀ®Ê¬¥Ï¥¤¥é¥¤¥È

      • ¥Ð¥Á¥ë¥¹¡¦¥³¥¢¥°¥é¥ó¥¹¶Ý (SNZ1969³ô)
        ¥Ð¥Á¥ë¥¹¡¦¥³¥¢¥°¥é¥ó¥¹¶Ý¤Ï¹³À¸ºîÍѤò»ý¤Ã¤Æ¤¤¤ë¥³¥¢¥°¥ê¥ó¤È¸Æ¤Ð¤ì¤ëÀ®Ê¬¤òʬÈ礷¤ÆÍÍ¡¹¤ÊºÙ¶Ý¤ò¸º¤é¤·¤Æ¤¯¤ì¤Þ¤¹¤¬¡¢Í­±×¤ÊºÙ¶Ý¤òÁý¤ä¤¹¤È¤¤¤¦ÁêÈ¿¤·¤¿ºîÍѤˤè¤êIJÆâ´Ä¶­¥Ð¥é¥ó¥¹¤òºÇŬ¤ËÊݤäƤ¯¤ì¤Þ¤¹¡£¥Ð¥Á¥ë¥¹¡¦¥³¥¢¥°¥é¥ó¥¹¶Ý¤Ï°ßIJ¤ÎÉÔ²÷¤Ê¾É¾õ¤ò²þÁ±¤·¤Æ¡¢ÆðÊØ¤Î²ò¾Ã¤Ë¸ú²Ì¤¬¤¢¤ê¤Þ¤¹¡£ÊØÈë¤ÎÊý¤Ï¡¢Ä²¤Îư¤­¤ò²þÁ±¤·¤ÆÊØÄ̤ò¤è¤¯¤¹¤ë¡¢ËÄËþ´¶¤ò²þÁ±¤¹¤ëƯ¤­¤â¤¢¤ë¤³¤È¤«¤éIJÆâ´Ä¶­¤¬²þÁ±¤µ¤ì¤ë¤³¤È¤ÇÊØÄ̤ò¥³¥ó¥È¥í¡¼¥ë¤·¤Æ¤¯¤ì¤Þ¤¹¡£
        ¥Ð¥Á¥ë¥¹¡¦¥³¥¢¥°¥é¥ó¥¹¶Ý¤ÏIJ¤Î±ÉÍÜÁǤȤʤëûº¿»éËûÀ¤È¤¤¤¦À®Ê¬¤òºî¤ê¡¢Ä²¤ò¾æÉפˤ·¤Æ¤¯¤ì¤ëƯ¤­¤â¤¢¤ê¤Þ¤¹¡£ÆÃ¤ËÍï»À¤È¸Æ¤Ð¤ì¤ëʪ¼Á¤Ë¤ÏIJ¤ò½¤Éü¤·¤Æ¡¢ÂçIJ¤¬¤ó¤òͽËɤ¹¤ëƯ¤­¤â³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£

      • ¥Ð¥Á¥ë¥¹¡¦¥¯¥é¥¦¥¸¶Ý (B106³ô)
        1942ǯ¤Ëȯ¸«¤µ¤ì¤Æ°ÊÍ褽¤ÎÍ­±×À­¤¬³Îǧ¤µ¤ì¤Æ¤¤¤ë¥×¥í¥Ð¥¤¥ª¥Æ¥£¥Ã¥¯¥¹¤Ç¤¹¡£ÆÃ¤ËµÞÀ­¤Î²¼Î¡¤ò²þÁ±¤¹¤ë¤Î¤ËÍ­¸ú¤Ç¤¹¡£¥¯¥í¥¹¥È¥ê¥¸¥¦¥à¡¦¥Ç¥£¥Õ¥£¥·¥ë¶Ý¤¬¸¶°ø¤Ë¤è¤ë²¼Î¡¤ËÂФ·¤Æ¤â¸ú²ÌŪ¤Ç¤¹¡£ËýÀ­¤Î²¼Î¡¤ËÂФ·¤Æ¤âÇÓÊØ¤ÎÉÑÅÙ¤äÆü¿ô¤ò¸º¾¯¤µ¤»¤ë¤Î¤ËÍ­¸ú¤Ç¤¹¡£ºÇ¶á¤Î¸¦µæ¤Ç¤ÏSIBO¤Ë¤âÆÃÉ®¤¹¤Ù¤­¸ú²Ì¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£Èó¾ï¤Ë¶¯¤¤ÂÑÀ­¤ò»ý¤Ã¤Æ¤¤¤ë¤³¤È¤«¤é¡¢¥Þ¥¤¥¯¥í¥Õ¥í¡¼¥é¥Ð¥é¥ó¥¹¤Ê¤É¤ÈÊ»ÍѤ·¤Æ¤âÌäÂê¤Ë¤Ê¤ë¤³¤È¤Ï¤¢¤ê¤Þ¤»¤ó¡£

      • ¥Ð¥Á¥ë¥¹¡¦¥µ¥Ö¥Æ¥£¥ê¥¹¶Ý (HS43³ô)
        ¥Ð¥Á¥ë¥¹¡¦¥µ¥Ö¥Æ¥£¥ê¥¹¶Ý¤Ï°­¶Ì¶Ý¤ÎÈË¿£¤òÍÞÀ©¤·¤Æ¡¢Á±¶Ì¶Ý¤ÎÈË¿£¤ò¥µ¥Ý¡¼¥È¤·¤Æ¤¯¤ì¤ë¡¢ÅÚ¾íͳÍè¤Î¥×¥í¥Ð¥¤¥ª¥Æ¥£¥¯¥¹¤Ç¤¹¡£¥Ð¥Á¥ë¥¹¡¦¥µ¥Ö¥Æ¥£¥ê¥¹¶Ý¤òÍѤ¤¤¿¸¦µæ¤Ç¤ÏËÄËþ´¶¤äÊØÈë¤Ê¤É¤ÎÉÔ²÷¤Ê¾É¾õ¤ò4½µ´Ö¤Ç²þÁ±¤·¤¿¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
        ¥Ð¥Á¥ë¥¹¡¦¥µ¥Ö¥Æ¥£¥ê¥¹¶Ý¤ÏIJ¤Î±ÉÍÜÁǤȤʤëûº¿»éËûÀ¤È¤¤¤¦À®Ê¬¤òºî¤ê¡¢Ä²¤ò¾æÉפˤ·¤Æ¤¯¤ì¤ëƯ¤­¤â¤¢¤ê¤Þ¤¹¡£ÆÃ¤ËÍï»À¤È¸Æ¤Ð¤ì¤ëʪ¼Á¤Ë¤ÏIJ¤ò½¤Éü¤·¤Æ¡¢ÂçIJ¤¬¤ó¤òͽËɤ¹¤ëƯ¤­¤â³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£

      • Ìȱ֥°¥í¥Ö¥ê¥óIgG
        IJÆâ¤Ç¤µ¤Þ¤¶¤Þ¤Ê°­¶ÌºÙ¶Ý¤äÆÇÁǤȷë¹ç¤·¡¢¤½¤ì¤é¤ò¸ú²ÌŪ¤ËÊØ¤È¤·¤ÆÇӽФ¹¤ë¤³¤È¤¬²Äǽ¤Ç¤¹¡£°­¶ÌºÙ¶Ý¤äÆÇÁǤòÇӽФ¹¤ë¤³¤È¤Ç°ßIJ¤Î½¤Éü¤ÈÌȱֵ¡Ç½¤òÀµ¾ï²½¤Ë¸ú²ÌŪ¤Ç¤¹¡£

        ¥Ê¥Á¥å¥í¥Ñ¥·¡¼¤Î¤È¾¼Ò¤ÎÀ½ÉʤȤΰ㤤¤Ï²¿¤Ç¤¹¤«¡©

        ¹³¶Ý¡¢À°Ä²¡¢Ä²´É½¤ÉüºîÍѤò¤¢¤ï¤»¤â¤Ä¥Ð¥Á¥é¥¹¶Ý¤È¡¢Ä²´ÉÊݸºÙ¶ÝÇӽкîÍѤÎÌȱ֥°¥í¥Ö¥ê¥ó¤Î¥À¥Ö¥ë¥¢¥¯¥·¥ç¥ó¤Ç¾®Ä²¤ÎIJÆâºÙ¶Ý¥Ð¥é¥ó¥¹¤ò¶¯ÎϤËÀ°¤¨¤Þ¤¹¡£¤Þ¤¿Àݼ褷³¤±¤ë¤³¤È¤Ç°­¶Ì¶Ý¤ä¥«¥ó¥¸¥¿¤Ê¤É¤ò»¦¤·¤Æ¡¢È¯À¸¤òÍÞÀ©¤µ¤»¤ë¤È¤¤¤¦¡¢Â¾¤Ë¤Ï¤Ê¤¤ÆÃħ¤ò¤â¤Ä¡ÖÆÃÊ̤˳«È¯¤µ¤ì¤¿¥×¥í¥Ð¥¤¥ª¥Æ¥£¥¯¥¹À½ÉʡפǤ¹¡£

        »ÈÍѤµ¤ì¤Æ¤¤¤ëÌȱ֥°¥í¥Ö¥ê¥óIgG¤ÏÆýÀ½Éʤò°ìÀڴޤޤʤ¤¹âÇ»ÅÙ¤ÎÌȱ֥°¥í¥Ö¥ê¥óIgG¤Ç¤¹¡£¹âÇ»ÅÙ¤ÎÌȱ֥°¥í¥Ö¥ê¥óIgG¤ÏIJÆâ¤Ç¤µ¤Þ¤¶¤Þ¤Ê°­¶ÌºÙ¶Ý¤äÆÇÁǤȷë¹ç¤·¡¢¤½¤ì¤é¤ò¸ú²ÌŪ¤ËÊØ¤È¤·¤ÆÇӽФµ¤»¤ë¤Î¤Ç¡¢°ßIJ¤Î½¤Éü¤ÈÌȱֵ¡Ç½¤òÀµ¾ï²½¤µ¤»¤Þ¤¹¡£

        ¥­¥é¡¼¥×¥í¥Ð¥¤¥ª¥Æ¥£¥Ã¥¯G ¤ª¾¤¤·¾å¤¬¤êÊý¤ÎÌܰÂ

        1Æü£±²ó£³¾û¿©¸å¤Ë¤ª¾¤¤·¾å¤¬¤ê¤¯¤À¤µ¤¤¡£

        ¥Þ¥¤¥¯¥í¥Õ¥í¡¼¥é¥Ð¥é¥ó¥¹¤ò¶õÊ¢»þ¤Ë¤ªÀݤꤤ¤¿¤À¤¯¤È¡¢SIBO¤Î²þÁ±¸ú²Ì¤¬¹â¤Þ¤ê¤Þ¤¹¡£

        SIBO¤«¤â¡©¥»¥ë¥Õ¥Á¥§¥Ã¥¯¥ê¥¹¥È¤Ç³Îǧ¡ª

        • ÊØÈë¤È²¼Î¡¤ò·«¤êÊÖ¤¹¡£
          0. Åö¤Æ¤Ï¤Þ¤é¤Ê¤¤
          1. ¤Ï¤¤¡¢¾É¾õ¤Ï·Ú¤¯¡¢ÉÑÅ٤Ϥ¿¤Þ¤Ë¤Ê¤ëÄøÅÙ
          2. ¤Ï¤¤¡¢¾É¾õ¤Ï¤½¤ì¤Û¤É¤Ò¤É¤¯¤Ï¤Ê¤¤¤¬¡¢ÉÑÅ٤Ϥ褯¤Ê¤ë¡£
          3. ¤Ï¤¤¡¢½Å¾É¤Ç1Æü¤ª¤­¤Ë¤Û¤ÜËèÆü¤Ê¤ë¡£

        • ²¼Î¡
          0. Åö¤Æ¤Ï¤Þ¤é¤Ê¤¤¡£
          1. ¤Ï¤¤¡¢¾É¾õ¤Ï·Ú¤¯¡¢ÉÑÅ٤Ϥ¿¤Þ¤Ë¤Ê¤ëÄøÅÙ
          2. ¤Ï¤¤¡¢¾É¾õ¤Ï¤½¤ì¤Û¤É¤Ò¤É¤¯¤Ï¤Ê¤¤¤¬¡¢ÉÑÅ٤Ϥ褯¤Ê¤ë¡£
          3. ¤Ï¤¤¡¢½Å¾É¤Ç¤Û¤ÜËèÆü¤Ê¤ë¡£

        • ÊØÈë
          0. Åö¤Æ¤Ï¤Þ¤é¤Ê¤¤¡£
          1. ¤Ï¤¤¡¢¾É¾õ¤Ï·Ú¤¯¡¢ÉÑÅ٤Ϥ¿¤Þ¤Ë¤Ê¤ëÄøÅÙ
          2. ¤Ï¤¤¡¢¾É¾õ¤Ï¤½¤ì¤Û¤É¤Ò¤É¤¯¤Ï¤Ê¤¤¤¬¡¢ÉÑÅ٤Ϥ褯¤Ê¤ë¡£
          3. ¤Ï¤¤¡¢½Å¾É¤Ç¤Û¤ÜËèÆü¤Ê¤ë¡£

        • ¥²¥Ã¥×
          0. ¤Û¤È¤ó¤É¤·¤Ê¤¤¡£
          1. ¤Ï¤¤¡¢¤Ï¤¿¤Þ¤Ë¤¹¤ë¡£
          2. ¤Ï¤¤¡¢ÉÑÈˤˤǤ롣
          3. ¤Ï¤¤¡¢¤Û¤ÜËèÆü¡¢Ëè¿©¸å¤Ëµ¯¤­¤ë¡£

        • ¤ª¤Ê¤é
          0. ¤Û¤È¤ó¤É¤·¤Ê¤¤¡£
          1. ¤Ï¤¤¡¢¤Ï¤¿¤Þ¤Ë¤¹¤ë¡¢¾¯¤·½­¤¦¡£
          2. ¤Ï¤¤¡¢ÉÑÈˤˤǤ롢Æ÷¤¤¤¬µ¤¤Ë¤Ê¤ë¡£
          3. ¤Ï¤¤¡¢¤Û¤ÜËèÆü¡¢¤Þ¤¿¤Ï¤È¤Æ¤â½­¤¤¡£

        • ¤ªÊ¢¤¬Ä¥¤ë¡£
          0. Åö¤Æ¤Ï¤Þ¤é¤Ê¤¤¡£
          1. ¤Ï¤¤¡¢¾É¾õ¤Ï·Ú¤¯¡¢ÉÑÅ٤Ϥ¿¤Þ¤Ë¤Ê¤ëÄøÅÙ
          2. ¤Ï¤¤¡¢¾É¾õ¤Ï¤½¤ì¤Û¤É¤Ò¤É¤¯¤Ï¤Ê¤¤¤¬¡¢ÉÑÅ٤Ϥ褯¤Ê¤ë¡£
          3. ¤Ï¤¤¡¢½Å¾É¤Ç¤Û¤ÜËèÆü¤Ê¤ë¡£

        • Ê¢Éô¤Îº¹¤·¹þ¤ß
          0. Åö¤Æ¤Ï¤Þ¤é¤Ê¤¤¡£
          1. ¤Ï¤¤¡¢¾É¾õ¤Ï·Ú¤¯¡¢ÉÑÅ٤Ϥ¿¤Þ¤Ë¤Ê¤ëÄøÅÙ
          2. ¤Ï¤¤¡¢¾É¾õ¤Ï¤½¤ì¤Û¤É¤Ò¤É¤¯¤Ï¤Ê¤¤¤¬¡¢ÉÑÅ٤Ϥ褯¤Ê¤ë¡£
          3. ¤Ï¤¤¡¢½Å¾É¤Ç¤Û¤ÜËèÆü¤Ê¤ë¡£

        • »éËÃÊØ¡ÊÊØ¤¬¿åÌ̤ËÉ⤤¤Æ¤¤¤¿¤ê¡¢ÊؤηÁ¤¬À°¤ï¤Ê¤¤¡Ë
          0. Åö¤Æ¤Ï¤Þ¤é¤Ê¤¤¡£
          1. ¤Ï¤¤¡¢¾É¾õ¤Ï·Ú¤¯¡¢ÉÑÅ٤Ϥ¿¤Þ¤Ë¤Ê¤ëÄøÅÙ
          2. ¤Ï¤¤¡¢¾É¾õ¤Ï¤½¤ì¤Û¤É¤Ò¤É¤¯¤Ï¤Ê¤¤¤¬¡¢ÉÑÅ٤Ϥ褯¤Ê¤ë¡£
          3. ¤Ï¤¤¡¢½Å¾É¤Ç¤Û¤ÜËèÆü¤Ê¤ë¡£

        • ¿©ÊªÁ¡°Ý¤ò¿¤¯´Þ¤ó¤À¿©ÉÊ¡ÊÆ¦¡¢°ò¡¢¤«¤Ü¤Á¤ã¡¢¥´¥Ü¥¦¡¢¥­¥ã¥Ù¥Ä¤Ê¤É¡Ë¤ò¿©¤Ù¤ë¤È¤ªÊ¢¤Î¾É¾õ¤¬°­²½¤¹¤ë¡£
          0. Åö¤Æ¤Ï¤Þ¤é¤Ê¤¤¡£
          1. ¤Ï¤¤¡¢¾É¾õ¤Ï·Ú¤¯¡¢ÉÑÅ٤Ϥ¿¤Þ¤Ë¤Ê¤ëÄøÅÙ
          2. ¤Ï¤¤¡¢¾É¾õ¤Ï¤½¤ì¤Û¤É¤Ò¤É¤¯¤Ï¤Ê¤¤¤¬¡¢ÉÑÅ٤Ϥ褯¤Ê¤ë¡£
          3. ¤Ï¤¤¡¢½Å¾É¤Ç¤Û¤ÜËèÆü¤Ê¤ë¡£

        • ÆýÀ½Éʤò¿©¤Ù¤ë¤È¾É¾õ¤¬°­²½¤¹¤ë¡£
          0. Åö¤Æ¤Ï¤Þ¤é¤Ê¤¤¡£
          1. ¤Ï¤¤¡¢¾É¾õ¤Ï·Ú¤¯¡¢ÉÑÅ٤Ϥ¿¤Þ¤Ë¤Ê¤ëÄøÅÙ
          2. ¤Ï¤¤¡¢¾É¾õ¤ÏÃæÄøÅÙ¡£
          3. ¤Ï¤¤¡¢½Å¾É¤Çɬ¤º°­²½¤¹¤ë¡£

        • ¥°¥ë¥Æ¥ó¡Ê¾®ÇþÊ´À½Éʡˤò¿©¤Ù¤ë¤È¾É¾õ¤¬°­²½¤¹¤ë¡£
          0. Åö¤Æ¤Ï¤Þ¤é¤Ê¤¤¡£
          1. ¤Ï¤¤¡¢¾É¾õ¤Ï·Ú¤¯¡¢ÉÑÅ٤Ϥ¿¤Þ¤Ë¤Ê¤ëÄøÅÙ
          2. ¤Ï¤¤¡¢¾É¾õ¤Ï¤½¤ì¤Û¤É¤Ò¤É¤¯¤Ï¤Ê¤¤¤¬¡¢ÉÑÅ٤Ϥ褯¤Ê¤ë¡£
          3. ¤Ï¤¤¡¢½Å¾É¤Çɬ¤º°­²½¤¹¤ë¡£

        • ¿©¤Ù¤ë¤È¾É¾õ¤¬°­²½¤¹¤ë¿©Éʤ¬¤¤¤¯¤Ä¤â¤¢¤ë¡£
          0. Åö¤Æ¤Ï¤Þ¤é¤Ê¤¤¡£
          1. ¤Ï¤¤¡¢¾É¾õ¤Ï·Ú¤¯¡¢1-2Éʤο©ÉʤΤߡ£
          2. ¤Ï¤¤¡¢¾É¾õ¤Ï¤½¤ì¤Û¤É¤Ò¤É¤¯¤Ï¤Ê¤¤¤¬¡¢¤¤¤¯¤Ä¤«¤Î¿©Éʤ¬Åö¤Æ¤Ï¤Þ¤ë¡£
          3. ¤Ï¤¤¡¢½Å¾É¤ÇÈó¾ï¤Ë¿¤¯¤Î¿©ÉʤËÈ¿±þ¤¹¤ë¡£

        • ËýÀ­ÈèÏ«
          0. Åö¤Æ¤Ï¤Þ¤é¤Ê¤¤¡£
          1. ¤Ï¤¤¡¢¾É¾õ¤Ï·Ú¤¯¡¢ÉÑÅ٤Ϥ¿¤Þ¤ËÈè¤ì¤ëÄøÅÙ
          2. ¤Ï¤¤¡¢¾É¾õ¤ÏÃæÄøÅ٤Ǥ褯Èè¤ì¤ë»þ¤¬¤¢¤ë¡£
          3. ¤Ï¤¤¡¢Èó¾ï¤Ë½Å¾É¤Ç¤Û¤ÜËèÆüÈè¤ì¤Æ¤¤¤ë¡£

        • ÂνŤθº¾¯
          0. Åö¤Æ¤Ï¤Þ¤é¤Ê¤¤¡£
          1. ¤Ï¤¤¡¢¾É¾õ¤Ï·Ú¤¤¡£
          2. ¤Ï¤¤¡¢¾É¾õ¤ÏÃæÄøÅÙ¡£
          3. ¤Ï¤¤¡¢Èó¾ï¤Ë½Å¾É¡£

        • ¥¤¥é¥¤¥é¡¢µ¤Ê¬¤ÎÊѲ½¡¢É԰¡¢¤¦¤Ä
          0. Åö¤Æ¤Ï¤Þ¤é¤Ê¤¤¡£
          1. ¤Ï¤¤¡¢¾É¾õ¤Ï·Ú¤¯¡¢ÉÑÅ٤Ϥ¿¤Þ¤Ë¤Ê¤ëÄøÅÙ
          2. ¤Ï¤¤¡¢¾É¾õ¤Ï¤½¤ì¤Û¤É¤Ò¤É¤¯¤Ï¤Ê¤¤¤¬¡¢ÉÑÅ٤Ϥ褯¤Ê¤ë¡£
          3. ¤Ï¤¤¡¢½Å¾É¤Çɬ¤º°­²½¤¹¤ë¡£

        • ¿©ÃæÆÇ¤Ë¤Ê¤Ã¤¿¤³¤È¤¬¤¢¤ë¡£
          0. ¤¤¤¤¤¨¡£
          5. ¤Ï¤¤¡£
            ·ë²Ì
            £°-£±£°ÅÀ¡§SIBO¤Î²ÄǽÀ­¤ÏÄ㤤¤Ç¤¹¡£
            £±£±-£²£°ÅÀ¡§SIBO¤Î²ÄǽÀ­¤¬¹â¤¤¤Ç¤¹¡£SIBO¤Ë¤Ä¤¤¤Æ¤â¤Ã¤È¾Ü¤·¤¯ÃΤ롣
            £²£±-£µ£°ÅÀ¡§SIBO¤Î²ÄǽÀ­¤¬Èó¾ï¤Ë¹â¤¤¤Ç¤¹¡£º£¤¹¤°¥­¥é¡¼¥×¥í¥Ð¥¤¥ª¥Æ¥£¥Ã¥¯G¤ÇSIBO¤Î¼£ÎŤò»Ï¤á¤Þ¤·¤ç¤¦¡£

            ¥­¥é¡¼¥×¥í¥Ð¥¤¥ª¥Æ¥£¥Ã¥¯G¤ÎÆâÍÆÀ®Ê¬

            3¥«¥×¥»¥ëÃæ¡§
            µíͳÍè·ìÀ¶Ìȱ֥°¥í¥Ö¥ê¥óÇ»½ÌÀ®Ê¬ (ImmunoLin®)¡¡1 g
            Immunoglobulin G (IgG)¡¡480 mg
            ¥Ð¥Á¥ë¥¹¡¦¥³¥¢¥°¥é¥ó¥¹¶Ý (SNZ1969³ô)¡¡ 26mg (20²¯CFU)
            ¥Ð¥Á¥ë¥¹¡¦¥¯¥é¥¦¥¸¶Ý (B106³ô)¡¡13mg (10²¯CFU)
            ¥Ð¥Á¥ë¥¹¡¦¥µ¥Ö¥Æ¥£¥ê¥¹¶Ý (HS43³ô)¡¡ 6.5mg (10²¯CFU)
            ¤½¤Î¾¤Î¸¶ºàÎÁ¡§¥Ù¥¸¥¿¥Ö¥ë¥«¥×¥»¥ë¡¢¥»¥ë¥í¡¼¥¹¡¢¥Þ¥°¥Í¥·¥¦¥à¥¹¥Æ¥¢¥ê¥ó»À±ö¡¢Æó»À²½¥±¥¤ÁÇ

            ¢¨Íñ¡¢ÆýÀ½ÉÊ¡¢ÂçÆ¦¡¢µû¡¢¥Ê¥Ã¥Ä¡¢¥Ô¡¼¥Ê¥Ã¥Ä¡¢¥°¥ë¥Æ¥ó¡¢¥¤¡¼¥¹¥È¡¢¹çÀ®Ãå¿§ÎÁ/¹áÎÁ/ÊݸÎÁ¤Ï»ÈÍѤ·¤Æ¤ª¤ê¤Þ¤»¤ó¡£
            ¢¨Ãæ¹ñÀ½¸¶ÎÁ¤Ï»ÈÍѤ·¤Æ¤ª¤ê¤Þ¤»¤ó¡£

            ¥¢¥á¥ê¥«À½

            ¥É¥¯¥¿¡¼¾®ß·¤Î¥ª¥ê¥¸¥Ê¥ë¥µ¥×¥ê¥á¥ó¥È¤Ï°ÂÁ´À­¤È·ë²Ì¤ò½Ð¤»¤ë¥µ¥×¥ê¥á¥ó¥Èºî¤ê¤Î¤¿¤á¸¶ÎÁ¡¢À½ÉʤȤâ¤Ë¸·¤·¤¤¸¡ºº´ð½à¤ò¥Ñ¥¹¤·¤¿À½ÉʤÀ¤±¤ò½Ð²Ù¤¤¤¿¤·¤Æ¤ª¤ê¤Þ¤¹¡£¸¶ÎÁ´ð½à¤Ë㤷¤¿¸¶ÎÁ¤¬Æþ²Ù¤¹¤ë¤Þ¤ÇÀ½Â¤¤ò¸«¹ç¤ï¤»¤ë¾ì¹ç¤â¤´¤¶¤¤¤Þ¤¹¤Î¤Ç¡¢ÉÊÀÚ¤ì¤ÎºÝ¤Ë¤ÏÆþ²Ù¤Þ¤Çº£¤·¤Ð¤é¤¯¤ªÂÔ¤Á¤¤¤¿¤À¤¯¤³¤È¤â¤´¤¶¤¤¤Þ¤¹¤¬¡¢²¿Â´¤´Íý²ò¤¤¤¿¤À¤±¤Þ¤¹¤È¹¬¤¤¤Ç¤´¤¶¤¤¤Þ¤¹¡£


            »²¾È

            1. Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (N Y ). 2007 Feb;3(2):112-22. PMID: 21960820; PMCID: PMC3099351. 2. Bures J, Cyrany J, Kohoutova D, Förstl M, Rejchrt S, Kvetina J, Vorisek V, Kopacova M. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010 Jun 28;16(24):2978-90. doi: 10.3748/wjg.v16.i24.2978. PMID: 20572300; PMCID: PMC2890937. 3. Soman RJ, Swamy MV. A prospective, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of SNZ TriBac, a three-strain Bacillus probiotic blend for undiagnosed gastrointestinal discomfort. Int J Colorectal Dis. 2019;34(11):1971-1978. doi:10.1007/s00384-019-03416-w 4. Detzel CJ, Horgan A, Henderson AL, et al. Bovine immunoglobulin/protein isolate binds pro-inflammatory bacterial compounds and prevents immune activation in an intestinal co-culture model. PLoS One. 2015;10(4):e0120278. Published 2015 Apr 1. doi:10.1371/journal.pone.0120278 5. Nyangale EP, Farmer S, Cash HA, Keller D, Chernoff D, Gibson GR. Bacillus coagulans GBI-30, 6086 Modulates Faecalibacterium prausnitzii in Older Men and Women. J Nutr. 2015;145(7):1446-1452. doi:10.3945/jn.114.199802 6. Dolin BJ. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome. Methods Find Exp Clin Pharmacol. 2009;31(10):655-659. doi:10.1358/mf.2009.31.10.1441078 7. Madempudi RS, Neelamraju J, Ahire JJ, Gupta SK, Shukla VK. Bacillus coagulans Unique IS2 in Constipation: A Double-Blind, Placebo-Controlled Study. Probiotics Antimicrob Proteins. 2020;12(2):335-342. doi:10.1007/s12602-019-09542-9 8. Gabrielli M, Lauritano EC, Scarpellini E, Lupascu A, Ojetti V, Gasbarrini G, Silveri NG, Gasbarrini A. Bacillus clausii as a treatment of small intestinal bacterial overgrowth. Am J Gastroenterol. 2009 May;104(5):1327-8. doi: 10.1038/ajg.2009.91. Epub 2009 Apr 7. PMID: 19352343 9. Sudha MR, Bhonagiri S, Kumar MA. Efficacy of Bacillus clausii strain UBBC-07 in the treatment of patients suffering from acute diarrhoea. Benef Microbes. 2013 Jun 1;4(2):211-6. doi: 10.3920/BM2012.0034. PMID: 23443952. 10. Ianiro G, Rizzatti G, Plomer M, et al. Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2018;10(8):1074. Published 2018 Aug 12. doi:10.3390/nu10081074 11. Choi CH, Kwon JG, Kim SK, et al. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial [published correction appears in Neurogastroenterol Motil. 2015 Nov;27(11):1684-5. Dosage error in article text]. Neurogastroenterol Motil. 2015;27(5):705-716. doi:10.1111/nmo.12544 12. Jasion VS, Burnett BP. Survival and digestibility of orally-administered immunoglobulin preparations containing IgG through the gastrointestinal tract in humans. Nutr J. 2015;14:22. Published 2015 Mar 7. doi:10.1186/s12937-015-0010-7 13. Petschow BW, Burnett B, Shaw AL, Weaver EM, Klein GL. Serum-derived bovine immunoglobulin/protein isolate: postulated mechanism of action for management of enteropathy. Clin Exp Gastroenterol. 2014;7:181-190. Published 2014 May 24. doi:10.2147/CEG.S62823

¤³¤Î¾¦ÉʤòÇã¤Ã¤¿¿Í¤Ï¤³¤ó¤Ê¾¦ÉʤâÇã¤Ã¤Æ¤¤¤Þ¤¹

¥Ô¥Ã¥¯¥¢¥Ã¥×

¤´ÍøÍÑ¥¬¥¤¥É

¤ª»Ùʧ¤¤ÊýË¡

¤ª»Ùʧ¤¤ÊýË¡

  • ÇÛÁ÷ÊýË¡¤Ë¥á¡¼¥ë¥×¥é¥¹¤ò¤´ÁªÂò¤Î¾ì¹ç¡¢¤´Ãíʸ¶â³Û¤Ë¤è¤ê´ØÀǤ¬É¬ÍפȤʤë¾ì¹ç¤¬¤´¤¶¤¤¤Þ¤¹¡£
    ¤½¤ÎºÝ¤Ë¤ÏÃíʸÆâÍÆ¤ò³Îǧ¸å¡¢e¥á¡¼¥ë¤Ç¤ªµÒÍͤËľÀܤªÃΤ餻¤¤¤¿¤·¤Þ¤¹¡£
    ¾Ü¤·¤¯¤ÏÇÛÁ÷¤Ë¤Ä¤¤¤Æ¤Î¥Ú¡¼¥¸¤ò¤´³Îǧ¤¯¤À¤µ¤¤¡£
  • ¥¯¥ì¥¸¥Ã¥È¥«¡¼¥É·èºÑ¤ò¤´´õ˾¤Î¤ªµÒÍͤÏPayPal¤ò¤´ÍøÍѤ¯¤À¤µ¤¤¡£
    ¾Ü¤·¤¯¤Ï¤ª»Ùʧ¤¤ÊýË¡¤Î¥Ú¡¼¥¸¤ò¤´³Îǧ¤¯¤À¤µ¤¤¡£

ÇÛÁ÷ÊýË¡¡¦Á÷ÎÁ¤Ë¤Ä¤¤¤Æ

ÇÛÁ÷ÊýË¡¤Ï£²¤Ä¤Î¥¿¥¤¥×¤«¤é¤´ÁªÂò¤¤¤¿¤À¤±¤Þ¤¹¡£

  • ¥á¡¼¥ë¥×¥é¥¹¡§¡¡ÆüḀ̈᡼¥ë¥×¥é¥¹¡Ê¤æ¤¦¤Ñ¤Ã¤¯¡Ë¤Ç¤ªÆÏ¤±¤¤¤¿¤·¤Þ¤¹¡£
    ÆüÄÌÂå°ú¤­¡§¡¡¤ª²Ùʪ¤ò¤ª¼õ¤±¼è¤ê¤ÎºÝ¤ËÂå¶â¤ò¤ª»Ùʧ¤¤¤¤¤¿¤À¤±¤Þ¤¹¡£
    ¢¨¤½¤ì¤¾¤ìÇÛÁ÷ÊýË¡¤Ë¤è¤êÆÃħ¤¬°Û¤Ê¤ê¤Þ¤¹¤Î¤Ç¾Ü¤·¤¯¤ÏÇÛÁ÷ÊýË¡¤Î¥Ú¡¼¥¸¤ò¤´³Îǧ¤¯¤À¤µ¤¤¡£

¤´»ÈÍѤÎÌܰ¤ˤĤ¤¤Æ

  • ¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¤Ï¡¢¤É¤ó¤Êɵ¤¤Î¿ÇÃÇ¡¢¼£ÎÅ¡¢²þÁ±¡¢¤Þ¤¿¤ÏͽËɤ¹¤ë¤³¤È¤ò°Õ¿Þ¤·¤Æ¤¤¤Þ¤»¤ó¡£¤Þ¤¿¡¢¤´¹ØÆþ¤Î¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¤Ï°å»Õ¤¬¸Ä¿Í¤Ë¹ç¤ï¤»¤Æ½èÊý¤¹¤ë¤â¤Î¤È¤Ï°Û¤Ê¤ê¤Þ¤¹¡£ÁªÂò¡¢¤´»ÈÍѤÏÁ´¤Æ¤´¼«¿È¤ÎÀÕǤ¤È¤Ê¤ê¤Þ¤¹¤³¤È¤òͽ¤á¤´Î»¾µ¤¯¤À¤µ¤¤¡£
  • °å»Õ¤Ë¤è¤ë¼£ÎÅ¡¦ÅêÌô¤ò¼õ¤±¤Æ¤¤¤ë¾ì¹ç¤Ï°åÌôÉʤȤÎÁê¸ßºîÍѤβÄǽÀ­¤¬À¸¤¸¤ë²ÄǽÀ­¤¬¤¢¤ê¤Þ¤¹¤Î¤Ç¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¤Î»ÈÍѤˤĤ¤¤Æ¤ÏôÅö°å»Õ¤Î»ØÆ³¤ò¼õ¤±¤Æ²¼¤µ¤¤¡£ÆÃ¤Ë°å»Õ¤ÎȽÃǤò·Ð¤º¤Ë¼£ÎÅ¡¦°åÌôÉʤλÈÍѤòÃæÃǤ·¡¢¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¤ò»ÈÍѤ¹¤ë¤è¤¦¤Ê¹Ô°Ù¤Ï ¡ÈÀäÂÐ¤Ë¡É ¤ª¤ä¤á²¼¤µ¤¤¡£
  • ¥á¡¼¥«¡¼¤Î¼¨¤¹ÍÑË¡ÍÑÎ̤ò¼é¤Ã¤Æ¤´»ÈÍѤ¯¤À¤µ¤¤¡£
  • »ÈÍѼԤÎÂÎÄ´¡¢ÂμÁ¤Ë¤è¤Ã¤Æ¤Ï¿ÈÂΤ˹ç¤ï¤Ê¤¤¤³¤È¤¬¤¢¤ê¤Þ¤¹¡£ÉÔ²÷¤ò´¶¤¸¤¿¾ì¹ç¤Ï°ÂÁ´¤Î¤¿¤áľ¤Á¤Ë¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¤Î»ÈÍѤòÃæ»ß¤·¤Æ²¼¤µ¤¤¡£
  • ¸Ä¿ÍÍ¢Æþ¤Ç°ìÅÙ¤ËÍ¢Æþ¤Ç¤­¤ë¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¤Î¿ôÎ̤ˤÏÀ©¸Â¤¬¤¢¤ê¤Þ¤¹¡£ÂçÎ̤ˤ´¹ØÆþ¤Ë¤Ê¤é¤º¡¢µ¬À©¤ÎÈÏ°ÏÆâ¤ÇɬÍ×ʬ¤Î¤ß¤ò¤´¹ØÆþ²¼¤µ¤¤¡£
  • ¸Ä¿ÍÍ¢Æþ¤Ç»ý¤Á¹þ¤Þ¤ì¤¿¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¤Ï¡¢¼«¸ÊÀÕǤ¤Ë¤è¤ë¡Ö¸Ä¿Í»ÈÍѡפΤߤ¬µö²Ä¤µ¤ì¤Æ¤ª¤ê¤Þ¤¹¡£¤Ç¤¹¤Î¤ÇË¡¿Í¡¦ÃÄÂÎ̾µÁ¤Ç¤Î¤´Ãíʸ¤Ï¤ª¼õ¤±¤¹¤ë¤³¤È¤Ï¤Ç¤­¤Þ¤»¤ó¡£¤Þ¤¿¡¢¸Ä¿ÍÍ¢Æþ¤·¤¿¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¤ò¾¿Í¤Ø¤Î¾ùÅÏ¡¦Å¾Ç䤹¤ë¤³¤È¤Ïǧ¤á¤é¤ì¤Æ¤ª¤ê¤Þ¤»¤ó¡£
  • ¢¨¥É¥¯¥¿¡¼¥µ¥×¥êUSA¤Ï¥¢¥á¥ê¥« ¥«¥ê¥Õ¥©¥ë¥Ë¥¢½£¤Î¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥ÈÈÎÇä¶È¼Ô¤Ç¤¹¡£¥¢¥á¥ê¥« ¥«¥ê¥Õ¥©¥ë¥Ë¥¢½£¤ÎË¡µ¬¤Ë½¾¤Ã¤¿É½µ­¡¢ÈÎÇä¤ò¹Ô¤Ã¤Æ¤ª¤ê¤Þ¤¹¡£

¡ú¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¤ÎÀâÌÀ¤Ë´Ø¤·¤Æ¤Ï¡¢¤¢¤¯¤Þ¤Ç°ìÈÌŪ¤Ê¾É¾õ¤ËÂФ·¤ÆÍ­¸ú¤Ç¤¢¤ë¤È¤¤¤¦¤â¤Î¤Ç¤¢¤ê¡¢Dr.Ozawa¤¬¸Ä¿Í¤ËÂФ·¤ÆÄ¾ÀÜ¥¢¥É¥Ð¥¤¥¹¤·¤¿¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£¤É¤¦¤¾¤´Íý²ò¤Î¾å¡¢¤´¹ØÆþ¤ò¤ª´ê¤¤¤¤¤¿¤·¤Þ¤¹¡£

Dr.Ozawa HP ¢ª http://www.ozawand.com/


¥¯¥ê¥Ë¥Ã¥¯HP
¥¯¥ê¥Ë¥Ã¥¯HP

ºÇ¿·¤Î¼«Á³ÎÅË¡¡¢
±ÉÍܾðÊó¤ò¿ï»þ¹¹¿·¤·¤Æ¤¤¤Þ¤¹¡£

¤ªµÒÍͤؤΥá¥Ã¥»¡¼¥¸

¡ÈËÜʪ¤Î¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¡É
¤Î¤ß¤ªÆÏ¤±¤·¤Þ¤¹¡£

¥É¥¯¥¿¡¼¥µ¥×¥êUSA¤Ç¤Ï¡¢»ä¤Î¥¯¥ê¥Ë¥Ã¥¯¤Ç¸ú²Ì¤¬¤¢¤Ã¤¿¡Ö¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¡×¤À¤±¤ò¥»¥ì¥¯¥È¤·¤Æ¤´¾Ò²ð¤·¤Æ¤¤¤Þ¤¹¡£Í½Ëɰ峨¡¢¥µ¥×¥ê¥á¥ó¥È¼£ÎŤÎÀè¿Ê¹ñ¥¢¥á¥ê¥«¤ÇÀ¸¤Þ¤ì¤¿¡Ö¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¡×¤Ç¤¹¤¬¡¢ÆüËܤǤϻÄǰ¤Ê¤³¤È¤Ë¤Þ¤À¤¢¤Þ¤ê¿»Æ©¤·¤Æ¤Ï¤¤¤Þ¤»¤ó¡£¥¢¥á¥ê¥«¤Ç¼«Á³ÎÅË¡¤Î¤Ò¤È¤Ä¤È¤·¤ÆÀ®²Ì¤ò¾å¤²¤Æ¤¤¤ë¡Ö¥É¥¯¥¿¡¼¥º¥µ¥×¥ê¥á¥ó¥È¡×¤ò¤¼¤Ò¤³¤Îµ¡²ñ¤ËÃΤäƤ¤¤¿¤À¤­¡¢ÂΤÎÉÔÄ´¤ä¤ªº¤¤ê¤Î¾É¾õ¤Î²þÁ±¡¢·ò¹¯°Ý»ý¤ËÌòΩ¤Æ¤Æ¤¤¤¿¤À¤¯¤³¤È¤ò´ê¤Ã¤Æ¤ª¤ê¤Þ¤¹¡£

Dr.Eiji Ozawa ND

¥×¥í¥Õ¥£¡¼¥ë

¼«Á³ÎÅË¡°å²ÊÂç³Ø¤ÇÁ´Êưì¤È¤¤¤ï¤ì¤ë Bastyr University ¤ò´¶È¸å¡¢°å»ÕÌȵö¤ò¼èÆÀ¡£¼«Á³ÎÅË¡°å»Õ¤È¤·¤Æ¥í¥µ¥ó¥¼¥ë¥¹¤Ç10ǯ°Ê¾å¡¢À¾ÍÎ°å³Ø¤ËÊѤï¤ëÁí¹çŪ¼£ÎŤËÎϤòÆþ¤ì¤Æ¤¤¤ë¡£
¥×¥í¥Õ¥£¡¼¥ë¤ò¤â¤Ã¤È¾Ü¤·¤¯



¥â¥Ð¥¤¥ë QR ¥³¡¼¥É

QR¥³¡¼¥É

¥á¥ë¥Þ¥¬¤Î¤´°ÆÆâ¡¡ÅÐÏ¿¡¦²ò½ü¤Ï¤³¤Á¤é
  • RSS1.0
  • ATOM0.3